Abstract
Recent reports confirm that the management of chronic anal fissure has undergone extensive re-evaluation during the past few years. This rejuvenation of interest is attributable to the application of neurochemical treatment, which has contributed to the tendency to treat the disease on an outpatient basis. The use of botulinum neurotoxin seems to be a promising and safe approach for the treatment of chronic anal fissure, particularly in patients at high risk for incontinence. Indeed, botulinum neurotoxin has been successfully used selectively to weaken the internal anal sphincter as a treatment for chronic anal fissure. It is also more efficacious than nitrate therapy, and is not related to the patient's willingness to complete treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brisinda G et al. (2002) In Scientific and Therapeutic Aspects of Botulinum Toxin. 269–285 (Eds Brin MF et al.) Philadelphia: Lippincott Williams & Wilkins
Lund JN and Scholefield JH (1996) Aetiology and treatment of anal fissure. Br J Surg 83: 1335–1344
Brisinda G et al. (2003) Gastrointestinal smooth muscles and sphincters spasms: treatment with botulinum neurotoxin. Curr Med Chem 10: 603–623
Maria G et al. (2002) Botulinum neurotoxin and other treatments for fissure-in-ano and pelvic floor disorders. Br J Surg 89: 950–961
Lund JN and Scholefield JH (1997) Internal sphincter spasm in anal fissure. Br J Surg 84: 1723–1724
Cook TA et al. (2001) The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders. Aliment Pharmacol Ther 15: 887–898
Bhardwaj R et al. (2000) Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures. Gut 46: 861–868
Brown AC et al. (1989) Histopathology of the internal anal sphincter in chronic anal fissure. Dis Colon Rectum 32: 680–683
Schouten W et al. (1996) Ischaemic nature of anal fissure. Br J Surg 83: 63–65
Shah V et al. (2004) Nitric oxide in gastrointestinal health and disease. Gastroenterology 126: 903–913
Maria G and Brisinda G (2000) Nonoperative management of chronic anal fissure. Dis Colon Rectum 43: 721–726
Maria G et al. (1999) Identification of anti-endothelial cell antibodies in patients with chronic anal fissure. Surgery 126: 535–540
Regadas FS et al. (1993) Pharmacological study of the internal and sphincter in patients with chronic anal fissure. Br J Surg 80: 799–801
Lindsey I et al. (2004) Chronic anal fissure. Br J Surg 91: 270–279
Nyam DC and Pemberton JH (1999) Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum 42: 1306–1310
Lund JN and Scholefield JH (1997) A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 349: 11–14
Nelson R (2004) A systematic review of medical therapy for anal fissure. Dis Colon Rectum 47: 422–431
Jonas M et al. (2001) A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum 44: 1074–1078
Pitt J et al. (2000) Alpha-1 adrenoceptor blockade: potential new treatment for anal fissures. Dis Colon Rectum 43: 800–803
MacKenzie I et al. (1982) The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7: 997–1006
Maria G and Brisinda G (2003) Chronic anal fissure: advances and insights in pathophysiology and treatment. Gastroenterology 125: 995–996
Brisinda D et al. (2003) Safety of botulinum neurotoxin treatment in patients with chronic anal fissure. Dis Colon Rectum 46: 419–420
Tonkin AL and Frewin DB (1999) Autonomic failure. In A Textbook of Clinical Disorders of the Autonomic Nervous System, 527–533 (Eds Mathias CJ and Bannister R) New York: Oxford University Press
Jost WH and Schimrigk K (1995) Botulinum toxin in therapy of anal fissure. Lancet 345: 188–189
Madalinski M et al. (1999) Botulinum toxin injection into only one point in the external anal sphincter: a modification of the treatment for chronic anal fissure. Endoscopy 31: S63
Gonzalez CP et al. (1999) The treatment of anal fissure with botulinum toxin. Gastroenterol Hepatol 22: 163–166
Maria G et al. (1998) Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens. Ann Surg 228: 664–669
Minguez M et al. (1999) Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum 42: 1016–1021
Brisinda G et al. (2002) Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery 131: 179–184
Mentes BB et al. (2003) Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure. Dis Colon Rectum 46: 232–237
Siproudhis L et al. (2003) Lack of effficacy of botulinum toxin in chronic anal fissure. Aliment Pharmacol Ther 18: 515–524
Tilney HS et al. (2001) Complication of botulinum toxin injections for anal fissure. Dis Colon Rectum 44: 1721–1724
Brisinda G et al. (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomized “Botox vs. Dysport” controlled trial. Aliment Pharmacol Ther 19: 695–701
Albanese A et al. (2001) In The Autonomic Nervous System. Part II. Dysfunctions. 613–663 (Ed. Appenzeller O) Amsterdam: Elsevier
Gui D et al. (1994) Botulinum toxin for chronic anal fissure. Lancet 344: 1127–1128
Jost WH and Schimrigk K (1994) Therapy of anal fissure using botulin toxin. Dis Colon Rectum 37: 1340
Mason PF et al. (1996) The management of chronic fissure in ano with botulinum toxin. J R Coll Surg Edinb 41: 235–238
Jost WH (1997) One hundred cases of anal fissure treated with botulin toxin: early and long-term results. Dis Colon Rectum 40: 1029–1032
Espi A et al. (1997) Therapeutic use of botulinum toxin in anal fissure. Int J Colorectal Dis 12: 163
Maria G et al. (1998) A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 338: 217–220
Maria G et al. (1998) Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens. Ann Surg 228: 664–669
Jost WH and Schrank B (1999) Repeat botulin toxin injections in anal fissure: in patients with relapse and after insufficient effect of first treatment. Dig Dis Sci 44: 1588–1589
Brisinda G et al. (1999) A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 341: 65–69
Fernandez LF et al. (1999) Botulinum toxin for the treatment of anal fissure. Dig Surg 16: 515–518
Madalinski MH (1999) Nonsurgical treatment modalities for chronic anal fissure using botulinum toxin. Gastroenterology 117: 516–517
Khademi A and Feldman DM (2000) A comparison of combination of botox (botulinum toxin) and nitroglycerin in the treatment of chronic anal fissure. Am J Gastroenterol 95: 2538
Maria G et al. (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg 179: 46–50
Lysy J et al. (2001) Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure. Gut 48: 221–224
Madalinski MH et al. (2001) Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepatogastroenterology 48: 977–979
Trzcinski R et al. (2002) Injections of botulinum A toxin for the treatment of anal fissures. Eur J Surg 168: 720–723
Colak T et al. (2002) A randomized trial of botulinum toxin vs lidocain pomade for chronic anal fissure. Acta Gastroenterol Belg 65: 187–190
Giral A et al. (2004) Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial. BMC Gastroenterol 4: 7
Wollina U and Konrad H (2002) Botulinum toxin A in anal fissures: a modified technique. J Eur Acad Dermatol Venereol 16: 469–471
Madalinski MH et al. (2002) Side effects of botulinum toxin injection for benign anal disorders. Eur J Gastroenterol Hepatol 14: 853–856
Author information
Authors and Affiliations
Corresponding author
Glossary
- β2 AGONISTS
-
Drugs that acts via β2 adrenergic receptors. They are used as a first-line therapy to alleviate asthma symptoms
- AMINOGLYCOSIDES
-
Potent bactericidal antimicrobiotical agents used in the treatment of various severe infections caused by aerobic Gram-negative bacteria
- BRACHIAL PLEXOPATHY
-
A decreased movement or sensation in the arm and shoulder caused by impaired function of the brachial plexus; it is a form of peripheral neuropathy
Rights and permissions
About this article
Cite this article
Brisinda, G., Cadeddu, F., Brandara, F. et al. Treating chronic anal fissure with botulinum neurotoxin. Nat Rev Gastroenterol Hepatol 1, 82–89 (2004). https://doi.org/10.1038/ncpgasthep0048
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0048
This article is cited by
-
Akuter analer Schmerz
Die Gastroenterologie (2022)
-
Botulinum toxin versus other therapies for treatment of chronic anal fissure
coloproctology (2020)
-
Oral Plus Local Antibiotics Significantly Reduce the Need for Operative Intervention in Chronic Anal Fissure: a Novel Finding
Indian Journal of Surgery (2018)
-
Analer Schmerz – Notfälle in der Proktologie
coloproctology (2018)
-
Conservative versus surgical treatment for chronic anal idiopathic fissure: a prospective randomized trial
Updates in Surgery (2013)